Skip to main content
Top
Published in: BMC Palliative Care 1/2024

Open Access 01-12-2024 | Cancer Fatigue | Research

Cancer-related fatigue and activities of daily living: lessons learned from the COVID-19 pandemic

Authors: Iveth Urbano Chamorro, Julio C. de la Torre-Montero

Published in: BMC Palliative Care | Issue 1/2024

Login to get access

Abstract

Background

Cancer-related fatigue is a prevalent condition in all stages of oncologic disease that is poorly diagnosed, with a negative impact on physical function to perform activities of daily living. Fatigue is also one of the main manifestations in post-COVID-19 syndrome, and few studies have explored the functionality of cancer patients after infection by the new coronavirus. This study was designed to assess cancer-related fatigue symptoms and their implications on physical function and quality of life during the pandemic.

Methodology

An observational study with a cross-sectional survey in cancer patients ≥ 18 years of age was conducted. The Functional Assessment of Chronic Illness Therapy - Fatigue Scale (FACIT-F), the perception of asthenia and performance status were evaluated, and the differences between groups according to the history of COVID-19 were calculated.

Results

A total of 60 cancer patients had an average age of 33.5 ± 10.11 years, 73.3% were female, and 98.3% had an Eastern Cooperative Oncology Group-Performance Status level < 2. Severe fatigue was found in 43.3% of patients, and the average FACIT-F score was 33.5 ± 10.11. The proportion of coronavirus infection was 13,3%, and the performance of this group was worse on the scale compared to the group without infection (25 ± 10,40 vs. 34,81 ± 9,50 [p = 0,009]). There was a significant correlation between visual analog scale values and FACIT-F scale scores (Pearson’s r = -0.76).

Conclusion

SARS-CoV-2 infection could increase cancer-related fatigue symptoms, limiting activities of daily living and impairing quality of life.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F et al. Cancer-related fatigue: ESMO Clinical Practice guidelines for diagnosis and treatment. Ann Oncol 2020 Mar 12. Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F et al. Cancer-related fatigue: ESMO Clinical Practice guidelines for diagnosis and treatment. Ann Oncol 2020 Mar 12.
3.
go back to reference Ma Y, He B, Jiang M, Yang Y, Wang C, Huang C, et al. Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis. Int J Nurs Stud. 2020;–11:111:103707.CrossRef Ma Y, He B, Jiang M, Yang Y, Wang C, Huang C, et al. Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis. Int J Nurs Stud. 2020;–11:111:103707.CrossRef
4.
go back to reference Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P. The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice. Breast 2017 -08;34:44–52. Fabi A, Falcicchio C, Giannarelli D, Maggi G, Cognetti F, Pugliese P. The course of cancer related fatigue up to ten years in early breast cancer patients: what impact in clinical practice. Breast 2017 -08;34:44–52.
5.
go back to reference Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, et al. Cancer-related fatigue in adolescents and young adults after Cancer Treatment: persistent and poorly managed. J Adolesc Young Adult Oncol. 2017;6(3):489–93.CrossRefPubMedPubMedCentral Spathis A, Hatcher H, Booth S, Gibson F, Stone P, Abbas L, et al. Cancer-related fatigue in adolescents and young adults after Cancer Treatment: persistent and poorly managed. J Adolesc Young Adult Oncol. 2017;6(3):489–93.CrossRefPubMedPubMedCentral
6.
go back to reference Pardo JMV, García AL. Aptitud sobrevenida tras incapacidad laboral prolongada por cáncer. Med Y Seguridad Del Trabajo. 2019;65(255):112–38.CrossRef Pardo JMV, García AL. Aptitud sobrevenida tras incapacidad laboral prolongada por cáncer. Med Y Seguridad Del Trabajo. 2019;65(255):112–38.CrossRef
7.
go back to reference Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012-05-29;9(7):414–26. Dantzer R, Meagher MW, Cleeland CS. Translational approaches to treatment-induced symptoms in cancer patients. Nat Rev Clin Oncol. 2012-05-29;9(7):414–26.
8.
go back to reference Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Reviews Clin Oncol 2014 -10;11(10):597–609. Bower JE. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nat Reviews Clin Oncol 2014 -10;11(10):597–609.
9.
go back to reference Peixoto da Silva S, Santos JMO, Costa E, Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with Sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;–06(3):619–35.CrossRef Peixoto da Silva S, Santos JMO, Costa E, Silva MP, Gil da Costa RM, Medeiros R. Cancer cachexia and its pathophysiology: links with Sarcopenia, anorexia and asthenia. J Cachexia Sarcopenia Muscle. 2020;–06(3):619–35.CrossRef
10.
go back to reference Gerber LH. Cancer-related fatigue: persistent, pervasive, and problematic. Phys Med Rehabilitation Clin North Am 2017 Febr 1,;28(1):65–88. Gerber LH. Cancer-related fatigue: persistent, pervasive, and problematic. Phys Med Rehabilitation Clin North Am 2017 Febr 1,;28(1):65–88.
11.
go back to reference Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020-02-05;21(2):17. Thong MSY, van Noorden CJF, Steindorf K, Arndt V. Cancer-related fatigue: causes and current treatment options. Curr Treat Options Oncol. 2020-02-05;21(2):17.
12.
go back to reference Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, Mitchell SA et al. Cancer-related fatigue and its impact on functioning. Cancer 2013-06-01;119 Suppl 11:2124–30. Minton O, Berger A, Barsevick A, Cramp F, Goedendorp M, Mitchell SA et al. Cancer-related fatigue and its impact on functioning. Cancer 2013-06-01;119 Suppl 11:2124–30.
13.
go back to reference Hernández-Quiles C, Bernabeu-Wittel M, Pérez-Belmonte LM, Macías-Mir P, Camacho-González D, Massa B, et al. Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases. BMJ Support Palliat Care. 2017;–09(3):300–7. Hernández-Quiles C, Bernabeu-Wittel M, Pérez-Belmonte LM, Macías-Mir P, Camacho-González D, Massa B, et al. Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases. BMJ Support Palliat Care. 2017;–09(3):300–7.
14.
go back to reference Chow R, Bruera E, Temel JS, Krishnan M, Im J, Lock M. Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis. Support Care Cancer. 2020;–05(5):2071–8.CrossRef Chow R, Bruera E, Temel JS, Krishnan M, Im J, Lock M. Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis. Support Care Cancer. 2020;–05(5):2071–8.CrossRef
15.
go back to reference Kokkonen K, Saarto T, Mäkinen T, Pohjola L, Kautio H, Järvenpää S et al. The functional capacity and quality of life of women with advanced breast cancer. Breast Cancer 2017 -01;24(1):128–36. Kokkonen K, Saarto T, Mäkinen T, Pohjola L, Kautio H, Järvenpää S et al. The functional capacity and quality of life of women with advanced breast cancer. Breast Cancer 2017 -01;24(1):128–36.
16.
go back to reference Rooijen SJv, Engelen MA, Scheede-Bergdahl C, Carli F, Roumen RMH, Slooter GD, et al. Systematic review of exercise training in colorectal cancer patients during treatment. Scand J Med Sci Sports. 2018;28(2):360–70.CrossRef Rooijen SJv, Engelen MA, Scheede-Bergdahl C, Carli F, Roumen RMH, Slooter GD, et al. Systematic review of exercise training in colorectal cancer patients during treatment. Scand J Med Sci Sports. 2018;28(2):360–70.CrossRef
17.
go back to reference Al Maqbali M, Hughes C, Gracey J, Rankin J, Dunwoody L, Hacker E. Quality assessment criteria: psychometric properties of measurement tools for cancer related fatigue. Acta Oncol. 2019;–09(9):1286–97.CrossRef Al Maqbali M, Hughes C, Gracey J, Rankin J, Dunwoody L, Hacker E. Quality assessment criteria: psychometric properties of measurement tools for cancer related fatigue. Acta Oncol. 2019;–09(9):1286–97.CrossRef
18.
go back to reference Lee LY, Cazier J, Angelis V, Arnold R, Bisht V, Campton NA et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020 06 20,;395(10241):1919–26. Lee LY, Cazier J, Angelis V, Arnold R, Bisht V, Campton NA et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet 2020 06 20,;395(10241):1919–26.
19.
go back to reference Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020 may 29,;21(7):893–903. Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020 may 29,;21(7):893–903.
20.
go back to reference Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED et al. Impact of the COVID-19 pandemic on Cancer Care: A Global Collaborative Study. JCO Glob Oncol 2020 -09;6:1428–38. Jazieh AR, Akbulut H, Curigliano G, Rogado A, Alsharm AA, Razis ED et al. Impact of the COVID-19 pandemic on Cancer Care: A Global Collaborative Study. JCO Glob Oncol 2020 -09;6:1428–38.
21.
go back to reference Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep 2020 05 08,;22(5):53. Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and Cancer: a Comprehensive Review. Curr Oncol Rep 2020 05 08,;22(5):53.
22.
go back to reference Amador M, Matias-Guiu X, Sancho-Pardo G, Contreras Martinez J, de la Torre-Montero JC, Peuelas Saiz A et al. Impact of the COVID-19 pandemic on the care of cancer patients in Spain. ESMO Open 2021-04-30;6(3):100157. Amador M, Matias-Guiu X, Sancho-Pardo G, Contreras Martinez J, de la Torre-Montero JC, Peuelas Saiz A et al. Impact of the COVID-19 pandemic on the care of cancer patients in Spain. ESMO Open 2021-04-30;6(3):100157.
23.
go back to reference Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;–03:101:93–135.CrossRef Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;–03:101:93–135.CrossRef
24.
go back to reference Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020;09–29:e13746. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020;09–29:e13746.
25.
go back to reference Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021 -02;9(2):129. Venkatesan P. NICE guideline on long COVID. Lancet Respir Med 2021 -02;9(2):129.
27.
go back to reference Mücke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015-05-30(5):CD006788. Mücke M, Cuhls H, Peuckmann-Post V, Minton O, Stone P, Radbruch L. Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev 2015-05-30(5):CD006788.
29.
go back to reference von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007-10-16;4(10):e296. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of Observational studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. 2007-10-16;4(10):e296.
31.
go back to reference Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784.CrossRefPubMedPubMedCentral Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15(11):e0240784.CrossRefPubMedPubMedCentral
32.
go back to reference Luo D, Mei B, Wang P, Li X, Chen X, Wei G, et al. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2024;–03(3):328–35.CrossRef Luo D, Mei B, Wang P, Li X, Chen X, Wei G, et al. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2024;–03(3):328–35.CrossRef
33.
go back to reference Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022-03-15;434:120162. Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci. 2022-03-15;434:120162.
34.
go back to reference Pinato DJ, Tabernero J, Bower M, Scotti L, Patel M, Colomba E, et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021;–12(12):1669–80.CrossRef Pinato DJ, Tabernero J, Bower M, Scotti L, Patel M, Colomba E, et al. Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study. Lancet Oncol. 2021;–12(12):1669–80.CrossRef
35.
go back to reference Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020 -10;6(4). Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res 2020 -10;6(4).
36.
go back to reference Baffert K, Darbas T, Lebrun-Ly V, Pestre-Munier J, Peyramaure C, Descours C et al. Quality of life of patients with Cancer during the COVID-19 pandemic. In Vivo 2021 Jan-Feb;35(1):663–70. Baffert K, Darbas T, Lebrun-Ly V, Pestre-Munier J, Peyramaure C, Descours C et al. Quality of life of patients with Cancer during the COVID-19 pandemic. In Vivo 2021 Jan-Feb;35(1):663–70.
37.
go back to reference Bargon CA, Batenburg MCT, van Stam LE, van der Mink DR, van Dam IE, van der Leij F, et al. Impact of the COVID-19 pandemic on patient-reported outcomes of breast Cancer patients and survivors. JNCI Cancer Spectr. 2021;–02(1):pkaa104.CrossRef Bargon CA, Batenburg MCT, van Stam LE, van der Mink DR, van Dam IE, van der Leij F, et al. Impact of the COVID-19 pandemic on patient-reported outcomes of breast Cancer patients and survivors. JNCI Cancer Spectr. 2021;–02(1):pkaa104.CrossRef
38.
go back to reference Ciążyńska M, Pabianek M, Szczepaniak K, Ułańska M, Skibińska M, Owczarek W et al. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology 2020 Jun 17,. Ciążyńska M, Pabianek M, Szczepaniak K, Ułańska M, Skibińska M, Owczarek W et al. Quality of life of cancer patients during coronavirus disease (COVID-19) pandemic. Psychooncology 2020 Jun 17,.
39.
go back to reference Kapoor A, Singhal MK, Bagri PK, Narayan S, Beniwal S, Kumar HS. Cancer related fatigue: a ubiquitous problem yet so under reported, under recognized and under treated. South Asian J Cancer 2015 Jan-Mar;4(1):21–3. Kapoor A, Singhal MK, Bagri PK, Narayan S, Beniwal S, Kumar HS. Cancer related fatigue: a ubiquitous problem yet so under reported, under recognized and under treated. South Asian J Cancer 2015 Jan-Mar;4(1):21–3.
40.
go back to reference Agarwal S, Garg R, Minhas V, Bhatnagar S, Mishra S, Kumar V, et al. To assess the prevalence and predictors of Cancer-related fatigue and its impact on quality of life in Advanced Cancer patients receiving Palliative Care in a Tertiary Care Hospital: a cross-sectional descriptive study. Indian J Palliat Care. 2020 Oct-Dec;26(4):523–7. Agarwal S, Garg R, Minhas V, Bhatnagar S, Mishra S, Kumar V, et al. To assess the prevalence and predictors of Cancer-related fatigue and its impact on quality of life in Advanced Cancer patients receiving Palliative Care in a Tertiary Care Hospital: a cross-sectional descriptive study. Indian J Palliat Care. 2020 Oct-Dec;26(4):523–7.
41.
go back to reference Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003 Dec 16,;1:79. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes 2003 Dec 16,;1:79.
42.
go back to reference Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, Kiehl M et al. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management. Crit Care 2017-04-14;21(1):89. Kroschinsky F, Stölzel F, von Bonin S, Beutel G, Kochanek M, Kiehl M et al. New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management. Crit Care 2017-04-14;21(1):89.
43.
go back to reference Linardou H, Gogas H. Toxicity management of immunotherapy for patients with metastatic melanoma. Ann Transl Med 2016 -07;4(14):272. Linardou H, Gogas H. Toxicity management of immunotherapy for patients with metastatic melanoma. Ann Transl Med 2016 -07;4(14):272.
44.
go back to reference Bartels MMTJ, Gal R, van der Velden JM, Verhoeff JJC, Verlaan JJ, Verkooijen HM. Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study. Clin Exp Metastasis. 2021;–04(2):209–17.CrossRef Bartels MMTJ, Gal R, van der Velden JM, Verhoeff JJC, Verlaan JJ, Verkooijen HM. Impact of the COVID-19 pandemic on quality of life and emotional wellbeing in patients with bone metastases treated with radiotherapy: a prospective cohort study. Clin Exp Metastasis. 2021;–04(2):209–17.CrossRef
45.
go back to reference Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020;223(5):725.e1-725.e9. Frey MK, Ellis AE, Zeligs K, Chapman-Davis E, Thomas C, Christos PJ et al. Impact of the coronavirus disease 2019 pandemic on the quality of life for women with ovarian cancer. Am J Obstet Gynecol. 2020;223(5):725.e1-725.e9.
46.
go back to reference Greco F, Altieri VM, Esperto F, Mirone V, Scarpa RM. Impact of COVID-19 pandemic on Health-Related Quality of Life in Uro-oncologic patients: what should we wait for? Clin Genitourin Cancer 2020 Jul 17. Greco F, Altieri VM, Esperto F, Mirone V, Scarpa RM. Impact of COVID-19 pandemic on Health-Related Quality of Life in Uro-oncologic patients: what should we wait for? Clin Genitourin Cancer 2020 Jul 17.
47.
go back to reference Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, et al. Stress and Symptom Burden in Oncology patients during the COVID-19 pandemic. J Pain Symptom Manage. 2020;60(5):e25–34.CrossRefPubMedPubMedCentral Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, et al. Stress and Symptom Burden in Oncology patients during the COVID-19 pandemic. J Pain Symptom Manage. 2020;60(5):e25–34.CrossRefPubMedPubMedCentral
48.
go back to reference Schmidt ME, Hermann S, Arndt V, Steindorf K. Prevalence and severity of long-term physicmotional, and cognitive fatigue across 15 different cancer entities. Cancer Med 2020 -11;9(21):8053–61. Schmidt ME, Hermann S, Arndt V, Steindorf K. Prevalence and severity of long-term physicmotional, and cognitive fatigue across 15 different cancer entities. Cancer Med 2020 -11;9(21):8053–61.
49.
go back to reference Ozdemir K, Keser I, Sen I, Ozgur Tan M. Investigating the relationships between quality of life, fatigue and leisure time physical activity in prostate cancer patients. J Back Musculoskelet Rehabilitation 2019 /01/01;32(3):497–503. Ozdemir K, Keser I, Sen I, Ozgur Tan M. Investigating the relationships between quality of life, fatigue and leisure time physical activity in prostate cancer patients. J Back Musculoskelet Rehabilitation 2019 /01/01;32(3):497–503.
50.
go back to reference Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020 06 20,;395(10241):1907–18. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 2020 06 20,;395(10241):1907–18.
51.
go back to reference Witlox L, Hiensch AE, Velthuis MJ, Steins Bisschop CN, Los M, Erdkamp FLG et al. Four-year effects of exercise on fatigue and physical activity in patients with cancer. BMC Med 2018-06-08;16(1):86. Witlox L, Hiensch AE, Velthuis MJ, Steins Bisschop CN, Los M, Erdkamp FLG et al. Four-year effects of exercise on fatigue and physical activity in patients with cancer. BMC Med 2018-06-08;16(1):86.
52.
go back to reference Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012-11-14;11:CD006145. Cramp F, Byron-Daniel J. Exercise for the management of cancer-related fatigue in adults. Cochrane Database Syst Rev 2012-11-14;11:CD006145.
53.
go back to reference Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, et al. Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin. 2019;–11(6):468–84.CrossRef Schmitz KH, Campbell AM, Stuiver MM, Pinto BM, Schwartz AL, Morris GS, et al. Exercise is medicine in oncology: engaging clinicians to help patients move through cancer. CA Cancer J Clin. 2019;–11(6):468–84.CrossRef
54.
go back to reference Wu F, Rotimi O, Laza-Cagigas R, Rampal T. The Feasibility and effects of a Telehealth-Delivered Home-based Prehabilitation Program for Cancer patients during the pandemic. Curr Oncol 2021-06-17;28(3):2248–59. Wu F, Rotimi O, Laza-Cagigas R, Rampal T. The Feasibility and effects of a Telehealth-Delivered Home-based Prehabilitation Program for Cancer patients during the pandemic. Curr Oncol 2021-06-17;28(3):2248–59.
55.
go back to reference Schmidt ME, Wiskemann J, Ulrich CM, Schneeweiss A, Steindorf K. Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials. Acta Oncol. 2017;–04(4):618–27.CrossRef Schmidt ME, Wiskemann J, Ulrich CM, Schneeweiss A, Steindorf K. Self-reported physical activity behavior of breast cancer survivors during and after adjuvant therapy: 12 months follow-up of two randomized exercise intervention trials. Acta Oncol. 2017;–04(4):618–27.CrossRef
56.
go back to reference Cifu G, Arem H. Adherence to lifestyle-related cancer prevention guidelines and breast cancer incidence and mortality. Ann Epidemiol 2018 -11;28(11):767–e7731. Cifu G, Arem H. Adherence to lifestyle-related cancer prevention guidelines and breast cancer incidence and mortality. Ann Epidemiol 2018 -11;28(11):767–e7731.
Metadata
Title
Cancer-related fatigue and activities of daily living: lessons learned from the COVID-19 pandemic
Authors
Iveth Urbano Chamorro
Julio C. de la Torre-Montero
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Palliative Care / Issue 1/2024
Electronic ISSN: 1472-684X
DOI
https://doi.org/10.1186/s12904-024-01437-z

Other articles of this Issue 1/2024

BMC Palliative Care 1/2024 Go to the issue